Home › Companies › FULGENT GENETICS INC. › 2023-2024

FULGENT GENETICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and FULGENT GENETICS INC.’s Form 8-K, filed May 16, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 6Ballot items
  • 245Asset managers
  • 1,672Fund votes
  • May 16, 2024Meeting date

Results at a glance

Meeting of May 16, 2024: 6 items on FULGENT GENETICS INC.’s Form 8-K, filed May 16, 2024: 6 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore FULGENT GENETICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by FULGENT GENETICS INC.

These tallies are FULGENT GENETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 16, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

FULGENT GENETICS INC. — official shareholder meeting results, meeting held May 16, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Ming Hsieh 20,071,185---- 314,4154,095,268 98%Not verified—
Elect Director: Michael Nohaile, Ph.D. 17,462,830---- 2,922,7704,095,268 86%Not verified—
Elect Director: Regina Groves 17,487,701---- 2,897,8994,095,268 86%Not verified—
Elect Director: Linda Marsh 15,854,682---- 4,530,9184,095,268 78%Not verified—
2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 24,238,701222,80419,363 ---- 99.0%Not verified—
3. Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers 19,786,239573,41125,950 --4,095,268 97%Not verified—

Source: FULGENT GENETICS INC., Form 8-K, filed with the SEC on May 16, 2024 — read the filing on EDGAR.

How asset managers voted at the FULGENT GENETICS INC. 2023-2024 meeting

Each item below shows how the 245 asset managers that disclosed a FULGENT GENETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Linda Marsh

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD
FOR: 15,854,682WITHHELD: 4,530,918
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Election of Directors: Linda Marsh

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Linda Marsh”): 15,854,682 for, 4,530,918 withheld, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 3,748,549 for, 2,425,846 withheld, 386 unknown.

FORWITHHOLD
FOR: 3,748,549WITHHOLD: 2,425,846UNKNOWN: 386
Largest asset managers voting on “Election of Directors: Linda Marsh” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock00 01,414,843Withhold
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity448,0150 09,645For
State Street297,4280 0571For
Charles Schwab289,4080 00For
Columbia Threadneedle00 0270,535Withhold
EA Series Trust00 0108,462Withhold
TIAA106,1640 00For
Nuveen84,3350 00For
BRIDGEWAY FUNDS INC00 052,708Withhold
Jackson National7,4690 041,720Mixed
Equitable00 048,957Withhold
EXCHANGE TRADED CONCEPTS TRUST00 045,130Withhold
Global X44,5180 00For
Federated Hermes00 037,593Withhold
QUANTITATIVE MASTER SERIES LLC00 036,135Withhold
First Trust00 036,116Withhold
Lincoln Financial21,5230 013,343Mixed
Invesco31,3940 00For
BNY Mellon00 030,532Withhold
JPMorgan00 028,949Withhold
American Century00 027,878Withhold
DWS00 027,210Withhold
Northern Trust25,7100 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

2. Elect Director: Michael Nohaile, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 17,462,830WITHHELD: 2,922,770
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Election of Directors: Michael Nohaile, Ph.D.

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Michael Nohaile, Ph.D.”): 17,462,830 for, 2,922,770 withheld, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 4,682,176 for, 1,492,219 withheld, 386 unknown.

FORWITHHOLD
FOR: 4,682,176WITHHOLD: 1,492,219UNKNOWN: 386
Largest asset managers voting on “Election of Directors: Michael Nohaile, Ph.D.” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,414,8430 00For
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity457,6600 00For
State Street297,4280 0571For
Charles Schwab00 0289,408Withhold
Columbia Threadneedle00 0270,535Withhold
EA Series Trust00 0108,462Withhold
TIAA00 0106,164Withhold
Nuveen00 084,335Withhold
BRIDGEWAY FUNDS INC00 052,708Withhold
Jackson National7,4690 041,720Mixed
Equitable32,0570 016,900Mixed
EXCHANGE TRADED CONCEPTS TRUST00 045,130Withhold
Global X00 044,518Withhold
Federated Hermes00 037,593Withhold
QUANTITATIVE MASTER SERIES LLC36,1350 00For
First Trust00 036,116Withhold
Lincoln Financial21,5230 013,343Mixed
Invesco00 031,394Withhold
BNY Mellon00 030,532Withhold
JPMorgan00 028,949Withhold
American Century00 027,878Withhold
DWS00 027,210Withhold
Northern Trust25,7100 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

3. Elect Director: Ming Hsieh

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 20,071,185WITHHELD: 314,415
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Election of Directors: Ming Hsieh

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Ming Hsieh”): 20,071,185 for, 314,415 withheld, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 6,146,153 for, 28,242 withheld, 386 unknown.

FOR
FOR: 6,146,153WITHHOLD: 28,242UNKNOWN: 386
Largest asset managers voting on “Election of Directors: Ming Hsieh” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,414,8430 00For
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity457,6600 00For
State Street297,9940 05For
Charles Schwab289,4080 00For
Columbia Threadneedle270,5350 00For
EA Series Trust108,4620 00For
TIAA106,1640 00For
Nuveen84,3350 00For
BRIDGEWAY FUNDS INC52,7080 00For
Jackson National49,1890 00For
Equitable48,9570 00For
EXCHANGE TRADED CONCEPTS TRUST45,1300 00For
Global X44,5180 00For
Federated Hermes37,5930 00For
QUANTITATIVE MASTER SERIES LLC36,1350 00For
First Trust36,1160 00For
Lincoln Financial34,8660 00For
Invesco31,3940 00For
BNY Mellon30,5320 00For
JPMorgan28,9490 00For
American Century27,8780 00For
DWS27,2100 00For
Northern Trust25,7100 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

4. Elect Director: Regina Groves

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 17,487,701WITHHELD: 2,897,899
Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Election of Directors: Regina Groves

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Regina Groves”): 17,487,701 for, 2,897,899 withheld, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 4,962,590 for, 1,211,805 withheld, 386 unknown.

FORWITHHOLD
FOR: 4,962,590WITHHOLD: 1,211,805UNKNOWN: 386
Largest asset managers voting on “Election of Directors: Regina Groves” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,414,8430 00For
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity457,6600 00For
State Street2330 0297,766Withhold
Charles Schwab289,4080 00For
Columbia Threadneedle00 0270,535Withhold
EA Series Trust00 0108,462Withhold
TIAA106,1640 00For
Nuveen84,3350 00For
BRIDGEWAY FUNDS INC00 052,708Withhold
Jackson National7,4690 041,720Mixed
Equitable32,0570 016,900Mixed
EXCHANGE TRADED CONCEPTS TRUST00 045,130Withhold
Global X44,5180 00For
Federated Hermes00 037,593Withhold
QUANTITATIVE MASTER SERIES LLC36,1350 00For
First Trust00 036,116Withhold
Lincoln Financial4,0230 030,843Mixed
Invesco31,3940 00For
BNY Mellon00 030,532Withhold
JPMorgan00 028,949Withhold
American Century00 027,878Withhold
DWS00 027,210Withhold
Northern Trust25,7100 00For

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

5. 3. Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 19,786,239AGAINST: 573,411
Details: description as filed, official tally, votes by 245 asset managers

Description as filed by funds: To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).

FULGENT GENETICS INC.’s own tally for this item (“3. Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers”): 19,786,239 for, 573,411 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 71 asset managers voting on “To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,414,8430 00For
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity457,6600 00For
State Street297,841158 00For
Charles Schwab289,4080 00For
Columbia Threadneedle270,5350 00For
EA Series Trust108,4620 00For
TIAA106,1640 00For
Nuveen84,3350 00For
BRIDGEWAY FUNDS INC052,708 00Against
Jackson National49,1890 00For
Equitable48,9570 00For
EXCHANGE TRADED CONCEPTS TRUST45,1300 00For
Global X44,5180 00For
Federated Hermes37,5930 00For
QUANTITATIVE MASTER SERIES LLC36,1350 00For
First Trust36,1160 00For
Lincoln Financial34,8660 00For
Invesco31,3940 00For
BNY Mellon30,5320 00For
JPMorgan28,9490 00For
American Century027,878 00Against
DWS27,2100 00For
Northern Trust25,7100 00For

Fund voting reports, all 71 managers: 6,053,040 for, 121,285 against, 386 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 196 asset managers voting on “To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock793,5296,011 00For
Park West Asset Management LLC729,7830 00For
State Street669,2526,487 00For
GEODE CAPITAL MANAGEMENT, LLC471,6340 00For
Charles Schwab293,9870 00For
Nuveen245,9660 00For
Divisadero Street Capital Management, LP236,2770 00For
Bridgewater184,7600 00For
Dimensional134,0520 00For
Northern Trust129,02514 00For
MELLON INVESTMENTS Corp127,3840 00For
TCW GROUP INC116,6000 00For
PRINCIPAL GLOBAL INVESTORS104,6780 00For
DE Shaw95,4460 00For
Point7292,8000 00For
JPMorgan68,2680 00For
Legal & General Investment Management Ltd065,696 00Against
BRIDGEWAY CAPITAL MANAGEMENT, LLC052,708 00Against
UBS044,597 00Against
Invesco38,6850 00For
Federated Hermes37,6070 00For
Legal & General Investment Management America Inc037,419 00Against
AMERIPRISE FINANCIAL INC35,7770 00For
Renaissance34,6570 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC034,199 00Against

Institutional-manager reports, all 196 managers: 5,148,130 for, 333,263 against, 7 not voted. Showing the 25 largest; see all in the interactive database.

6. 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 24,238,701AGAINST: 222,804
Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

FULGENT GENETICS INC.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 24,238,701 for, 222,804 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 6,047,296 for, 127,144 against, 386 unknown.

FOR
FOR: 6,047,296AGAINST: 127,144UNKNOWN: 386
Largest asset managers voting on “To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting f” at FULGENT GENETICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock1,414,8430 00For
Vanguard1,391,4050 00For
Dimensional881,7280 00For
Fidelity457,6600 00For
State Street297,97722 00For
Charles Schwab289,4080 00For
Columbia Threadneedle270,5350 00For
EA Series Trust0108,462 00Against
TIAA106,1640 00For
Nuveen84,3350 00For
BRIDGEWAY FUNDS INC52,7080 00For
Jackson National49,1890 00For
Equitable48,9570 00For
EXCHANGE TRADED CONCEPTS TRUST45,1300 00For
Global X44,5180 00For
Federated Hermes37,5930 00For
QUANTITATIVE MASTER SERIES LLC36,1350 00For
First Trust36,1160 00For
Lincoln Financial34,8660 00For
Invesco31,3940 00For
BNY Mellon30,5320 00For
JPMorgan28,9490 00For
American Century27,8780 00For
DWS27,2100 00For
Northern Trust25,7100 00For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

Largest FULGENT GENETICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 29,890,000 shares outstanding at the time of that meeting.

Fund voting reports: top FULGENT GENETICS INC. shareholders by shares voted on “To approve, on an advisory basis, compensation awarded to the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 4.73%
2Vanguard 4.66%
3Dimensional 2.95%
4Fidelity 1.53%
5State Street 1.00%
6Charles Schwab 0.97%
7Columbia Threadneedle 0.91%
8EA Series Trust 0.36%
9TIAA 0.36%
10Nuveen 0.28%
Institutional-manager reports: top FULGENT GENETICS INC. shareholders by shares voted on “To approve, on an advisory basis, compensation awarded to the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 2.67%
2Park West Asset Management LLC 2.44%
3State Street 2.26%
4GEODE CAPITAL MANAGEMENT, LLC 1.58%
5Charles Schwab 0.98%
6Nuveen 0.82%
7Divisadero Street Capital Management, LP 0.79%
8Bridgewater 0.62%
9Dimensional 0.45%
10Northern Trust 0.43%

Reported FULGENT GENETICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

FULGENT GENETICS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Ming Hsieh 28.56% DEF14A
BlackRock 9.95% 13F
Dimensional Fund Advisors 4.50% 13F
Vanguard Group 3.95% 13F
Hanlin Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. 2.84% DEF14A
State Street 2.76% 13F
Millennium Management 2.39% 13F
Geode Capital 1.58% 13F
JPMorgan Chase 1.00% 13F
Charles Schwab 0.99% 13F

Percentages above are of 29,890,000 shares outstanding, as reported by FULGENT GENETICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FULGENT GENETICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At FULGENT GENETICS INC.'s shareholder meeting held May 16, 2024, in the 2023-2024 proxy season, 245 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,672 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, compensation awarded to the Company's named executive… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: FULGENT GENETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 16, 2024.

FULGENT GENETICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.